Real-time enrollment status for this pneumococcal infection clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 3:49 AM UTC
| NCT Number | NCT07300267 |
| Recruiting Status | Recruiting |
| Condition | Pneumococcal Infection |
| Phase | PHASE1 |
| Target Enrollment | 210 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | April 17, 2026 (Apr 17, 2026) |
As of August 28, 2026: Clinical trial NCT07300267 is currently recruiting participants. This phase1 study for pneumococcal infection is actively seeking new participants at 14 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07300267 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07300267 was last updated Apr 17, 2026 (April 17, 2026). HelloStudys verifies this status automatically.